⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001778491

Minkow Emily

Reports to the SEC for 1 company · NEW YORK, NY

Transactions

8

Companies

1

Filings

3

CIK

0001778491

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-01-22	Prevail Therapeutics Inc.U Disposition from Tender	Chief Business Officer	UDisposition from Tender	−13K sh	—	—	0
2021-01-22	Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−149K sh	—	—	0
2021-01-22	Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−105K sh	—	—	0
2021-01-22	Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−109K sh	—	—	0
2021-01-22	Prevail Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−54K sh	—	—	0
2020-02-19	Prevail Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+54K sh	—	—	54,000
2019-12-24	Prevail Therapeutics Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+13K sh	$0.18	+$2,340	13,000
2019-12-24	Prevail Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−13K sh	—	—	149,000

Recent filings

3

Accepted (ET)
Jan 264
Minkow Emily0001209191-21-005432
SEC(opens sec.gov)
Mar 114
Minkow Emily0001209191-20-018129
SEC(opens sec.gov)
Mar 114
Minkow Emily0001209191-20-018117
SEC(opens sec.gov)

Companies

1

Prevail Therapeutics Inc.Chief Business Officer

Address

C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940

NEW YORK, NY, 10016